PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company - Preclinical Oncology Services Limited (PRECOS), a leading pre-clinical research and development service with a specific focus on oncology, announces its official launch following its spin-out from the University of Nottingham
Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company

 

NewswireToday - /newswire/ - Nottingham, United Kingdom, 2010/09/09 - Preclinical Oncology Services Limited (PRECOS), a leading pre-clinical research and development service with a specific focus on oncology, announces its official launch following its spin-out from the University of Nottingham.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The newly formed company combines the innovation of one of the Country's leading universities with the scientific background and expertise of multi-disciplinary scientists.
This places the company in an optimal position to deliver specialist services, backed by significant industry expertise and cutting-edge technology, to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs.

PRECOS was officially launched as a specialist business unit of the University of Nottingham, UK in 2004, having evolved from the research expertise of the Division of Pre-clinical Oncology (formerly Academic Unit of Cancer Studies). This unit has had successful collaborations with pharmaceutical and biotech companies in Europe, US and Japan for over a decade. The newly launched company offers the advantages of both academic and industrial scientific approaches to deliver a unique skill set to the global healthcare industry, providing high quality, solutions-driven, tailored services.

Headed by Professor Sue Watson, who will act as Chief Scientific Officer and Dr Rajendra Kumari, Chief Operations Officer, PRECOS will continue to advance its world leading work in the evaluation of potential therapeutic agents, regimens and basic research into tumour initiation and development.
Professor Watson comments: "The spin-out of the new company is an exciting time for us. Our extensive experience as a specialised research and development service has made PRECOS a trusted and preferred partner for some of the world's leading oncology research companies. PRECOS occupies a niche in global pre-clinical R&D and is ideally positioned to exploit the growing cancer therapy market and we are looking forward to translating our laboratory expertise in cancer drug development into medicines with real patient benefits."

The need for specialist service providers, such as PRECOS, is driven by increasing regulatory and scientific rigour and the pressure to reduce ever-increasing cancer drug attrition rates and R&D costs though outsourcing to identify potential lead candidates as early as possible. PRECOS can provide a tailored approach to all research objectives, whether a one-off service or a complete research programme. The company has unique patient-relevant models, closely reflecting the patient situation for each aspect of cancer progression encompassing pre-cancerous lesions, primary tumours and metastasis. Due to the high attrition rate within the pharmaceutical and biotech industry, there is a need for more patient-relevant and predictive cancer modelling and PRECOS is well-placed to fast-track these new agents, from concept into the clinic, through innovative approaches.

PRECOS' unique services offer advantages over traditional screening models as they specifically help researchers to identify drugs with a high chance of success and focus expensive resources. New drugs can be screened early in the research process for anti-cancer activity, meaning drugs with potential beneficial effects can be identified and pursued, whilst others can be rejected. This allows companies to concentrate efforts on those compounds most likely to have a therapeutic effect in patients with cancer, eliminating wasted time and money on unsuccessful drugs.

For more information on PRECOS, please call, +44 (0)870 166 6234, email, enquiries[.]precos.co.uk

About PRECOS Ltd
PRECOS Ltd (precos.co.uk) is a flexible pre-clinical research and development service with a specific focus on oncology, with an established track record in providing expert support to direct cancer drug development projects from concept to clinic. PRECOS evaluates the innovative cancer medicines of the future in patient-relevant models to ensure that pre-clinical efficacy assessment is predictive of how the drug is likely to behave in clinical trials with cancer patients. The PRECOS team of expert scientists assist in the selection and execution of appropriate analytical systems by a staged approach of in vitro studies, in vivo model development, subsequent in vivo mechanistic and therapeutic evaluations and post-study analyses, all conveyed with added value through specialist scientific interpretation of the data. PRECOS scientists apply cutting-edge technology and ideas to individual research programmes and delivers a flexible, tailored approach to all research objectives, whether a one-off service or a complete research programme.

PRECOS, an acronym of Pre-Clinical Oncology Services, was officially launched as a specialist business unit of the University of Nottingham (UK) in 2004. PRECOS evolved from the research expertise of the Division of Pre-clinical Oncology (formerly Academic Unit of Cancer Studies), which had successful collaborations with pharmaceutical and biotech companies in the UK, EU, US and Japan for over a decade.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

PRECOS |
Publisher Contact: Sarah Evans - Scottpr.com 
+44 1477 539539 precos[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)